Lee, P. and Kim, C.E. and Kim, C.Y. and Lin, W. W. and Habil, H. and Dyachkova, Y. and McBride, M. and Dossenbach, M. (2008) Long-term, naturalistic treatment with olanzapine, risperidone, quetiapine, or haloperidol monotherapy: 24-month results from the intercontinental schizophrenia outpatient health outcomes (IC-SOHO) study. International Journal of Psychiatry in Clinical Practice, 12 (3). pp. 215-227. ISSN 1365-1501, DOI https://doi.org/10.1080/13651500801976634.
Full text not available from this repository.Abstract
Objective. To compare the effectiveness of olanzapine, risperidone, quetiapine, or haloperidol monotherapy in patients with schizophrenia who were treated in routine clinical practice settings for a period of 2 years. The incidence and persistence of adverse events encountered during long-term therapy are also reported. Method. Outpatients with schizophrenia who entered this 3-year, prospective, observational study were classified according to their initially prescribed antipsychotic monotherapy: olanzapine (n=3222), risperidone (n=1116), quetiapine (n=189), or haloperidol (n=256). Patients were included in the analysis for as long as this treatment was maintained. Results. Over 2 years, olanzapine recipients had significantly (P0.001) greater reduction in overall CGI-S score (and the negative, depressive, and cognitive symptoms domains), lower incidence of sexual and motor dysfunction, and greater odds of response compared to risperidone or haloperidol-treated patients. However, olanzapine patients gained more weight than patients in other treatment groups. The incidence of motor dysfunction was significantly (P0.001) greater in haloperidol-treated patients, relative to the atypical treatment groups. Conclusion. The results of this observational study indicate that, in these patients with schizophrenia, long-term monotherapy with olanzapine may offer benefits over risperidone and haloperidol, but the potential for weight gain should be considered in the clinical management of these patients.
| Item Type: | Article |
|---|---|
| Funders: | UNSPECIFIED |
| Uncontrolled Keywords: | Antipsychotic agents, olanzapine, risperidone, schizophrenia, treatment outcome |
| Subjects: | R Medicine |
| Divisions: | Faculty of Medicine |
| Depositing User: | Ms Haslinda Lahuddin |
| Date Deposited: | 17 Dec 2014 01:52 |
| Last Modified: | 17 Dec 2014 01:52 |
| URI: | http://eprints.um.edu.my/id/eprint/11046 |
Actions (login required)
 |
View Item |
